SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001799191-23-000040
Filing Date
2023-08-30
Accepted
2023-08-30 15:04:36
Documents
13
Period of Report
2023-08-30
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K toi-20230830.htm   iXBRL 8-K 30318
  Complete submission text file 0001799191-23-000040.txt   200884

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT toi-20230830.xsd EX-101.SCH 2306
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT toi-20230830_def.xml EX-101.DEF 15976
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT toi-20230830_lab.xml EX-101.LAB 30813
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT toi-20230830_pre.xml EX-101.PRE 16714
7 EXTRACTED XBRL INSTANCE DOCUMENT toi-20230830_htm.xml XML 4189
Mailing Address 18000 STUDEBAKER RD SUITE 800 CERRITOS CA 90703
Business Address 18000 STUDEBAKER RD SUITE 800 CERRITOS CA 90703 562-735-3226
Oncology Institute, Inc. (Filer) CIK: 0001799191 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39248 | Film No.: 231224953
SIC: 8011 Services-Offices & Clinics of Doctors of Medicine